C25H36O4
Neat
400.56
16319-93-0; 3-Ethoxy-17-hydroxypregna-3, 5-dien-20-one 17-acetate; [(8R, 9S, 10R, 13S, 14S, 17R)-17-acetyl-3-ethoxy-10, 13-dimethyl-1, 2, 7, 8, 9, 11, 12, 14, 15, 16-decahydrocyclopenta[a]phenanthren-17-yl] acetate; Pregna-3, 5-dien-20-one, 17-(acetyloxy)-3-ethoxy-; EINECS 240-396-4; GLUPBNAYNWZRSJ-RFXJPFPRSA-N; Hydroxyprogesterone Impurity 9; Medroxyprogesterone Impurity N1; AKOS030241131; NS00054921; 3-Ethoxy-17-hydroxy-pregna-3, 5-dien-20-one Acetate; (17-Acetyl-3-ethoxy-10, 13-dimethyl-1, 2, 7, 8, 9, 11, 12, 14, 15, 16-decahydrocyclopenta[a]phenanthren-17-yl)acetate; (8R, 9S, 10R, 13S, 14S, 17R)-17-acetyl-3-ethoxy-10, 13-dimethyl-2, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 and 17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate
[(8R, 9S, 10R, 13S, 14S, 17R)-17-acetyl-3-ethoxy-10, 13-dimethyl-1, 2, 7, 8, 9, 11, 12, 14, 15 and 16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
InChI=1S/C25H36O4/c1-6-28-19-9-12-23(4)18(15-19)7-8-20-21(23)10-13-24(5)22(20)11-14-25(24,16(2)26)29-17(3)27/h7,15,20-22H,6,8-14H2,1-5H3/t20-,21+,22+,23+,24+,25+/m1/s1